Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Prothena Corp. plc

Start price
Target price
Perf. (%)
€62.00
24.06.23
€90.00
31.03.26
-70.48%
05.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 70%
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€44.20
24.06.23
€60.00
31.12.25
-77.79%
04.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 60%
buy
Voyager Therapeutics Inc

Start price
Target price
Perf. (%)
€10.60
24.06.23
€20.00
31.12.25
-34.43%
05.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 70%
buy
Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€5.70
07.09.22
€10.00
31.12.24
8.78%
04.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
07.09.22 60%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€208.80
07.09.22
€300.00
31.12.24
10.97%
05.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
07.09.22 70%
buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€29.80
07.09.22
€50.00
31.12.25
11.41%
05.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
07.09.22 80%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€196.52
08.01.22
€915.00
14.01.27
122.75%
05.07.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
ROE higher than 15% per year
Karakorum 
08.01.22 80%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€196.52
08.01.22
€915.00
14.01.27
122.75%
05.07.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
ROE higher than 15% per year
Karakorum 
08.01.22 80%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€196.52
08.01.22
€915.00
14.01.27
122.75%
05.07.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
ROE higher than 15% per year
Karakorum 
08.01.22 80%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.48
30.09.16
€98.00
08.09.26
12.54%
05.07.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
ValueFreak 
05.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.48
30.09.16
€98.00
08.09.26
12.54%
05.07.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
ValueFreak 
05.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.48
30.09.16
€98.00
08.09.26
12.54%
05.07.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
ValueFreak 
05.08.19 50%